10-K/A Filing

ETHEMA HEALTH CORP CIK: 792935 FY 2014

Filing Information

Form Type	10-K/A
Accession Number	`0000721748-15-000281`
Period End Date	20141231
Filing Date	20150416
Fiscal Year	2014
Fiscal Period	FY
XBRL Instance	grst-20141231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 39 Income Statement 20 Cash Flow Statement 42 Stockholders Equity 24

Balance Sheet 39 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	$88.15K	USD	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash	`Cash`	$-126.07K	USD	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNet`	$164.83K	USD	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common Stock Shares Issued	`CommonStockSharesIssued`	46.13M	shares	Point-in-time
Common Stock Shares Issued	`CommonStockSharesIssued`	41.07M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$46.27K	USD	Point-in-time
Common Stock Shares Outstanding	`CommonStockSharesOutstanding`	41.07M	shares	Point-in-time
Common Stock Shares Outstanding	`CommonStockSharesOutstanding`	46.13M	shares	Point-in-time
Due on sale of Subsidiary	`DueOnSaleOfSubsidiary`	$493.81K	USD	Point-in-time
Current assets - held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperation`	-	USD	Point-in-time
Total current assets	`AssetsCurrent`	$793.06K	USD	Point-in-time
Cash - Restricted	`RestrictedCashAndCashEquivalents`	$86.20K	USD	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$256.54K	USD	Point-in-time
Long term assets - held for resale	`AssetsHeldForSaleLongLivedFairValueDisclosure`	-	USD	Point-in-time
Total assets	`Assets`	$1.14M	USD	Point-in-time
Bank overdraft	`BankOverdrafts`	-	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$808.97K	USD	Point-in-time
Taxes payable	`AccruedIncomeTaxesCurrent`	$2.81M	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$143.84K	USD	Point-in-time
Convertible notes payable	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Current portion of loan payable	`NotesAndLoansPayableCurrent`	$7.62K	USD	Point-in-time
Short Term loan	`ShortTermBorrowings`	$29.76K	USD	Point-in-time
Related party notes	`NotesPayableRelatedPartiesClassifiedCurrent`	$51.34K	USD	Point-in-time
Current liabilities - held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.85M	USD	Point-in-time
Loan payable	`LongTermLoansPayable`	$18.46K	USD	Point-in-time
Total liabilities	`Liabilities`	$3.87M	USD	Point-in-time
Common stock; $0.01 par value, 500,000,000 shares authorized; 46,134,787 and 41,065,564 shares issued and outstanding at December 31, 2014 and 2013 respectively	`CommonStockValue`	$461.32K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$16.13M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossBeforeTax1`	$245.19K	USD	Point-in-time
Accumulated deficit	`CumulativeEarningsDeficit`	$-19.57M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-3.07M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-3.21M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-2.73M	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$1.14M	USD	Point-in-time

Income Statement 20 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	$3.42M	USD	Annual
Depreciation	`DepreciationAndAmortization`	$83.70K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$903.02K	USD	Annual
Management fees	`SponsorFees`	$122.27K	USD	Annual
Professional fees	`ProfessionalFees`	$308.35K	USD	Annual
Rent	`LeaseAndRentalExpense`	$454.38K	USD	Annual
Rent	`LeaseAndRentalExpense`	$412.49K	USD	Annual
Salaries and wages	`SalariesWagesAndOfficersCompensation`	$2.93M	USD	Annual
Total operating expenses	`CostsAndExpenses`	$4.76M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-1.34M	USD	Annual
Interest expense	`InterestExpense`	$-310.58K	USD	Annual
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-1.65M	USD	Annual
Loss from discontinued operations, net of tax	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	$-248.18K	USD	Annual
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.90M	USD	Annual
Foreign currency translation adjustment	`ForeignCurrencyTransactionGainLossUnrealized`	$71.36K	USD	Annual
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.83M	USD	Annual
Basic and diluted loss per common share- continuing operations	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.04	USD	Annual
Basic and diluted loss per common share- discontinued operations	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare`	-	USD	Annual
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	Annual
Weighted average outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	46.70M	shares	Annual

Cash Flow Statement 42 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.90M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.53M	USD	Annual
Net loss from discontinued operations, net of tax	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	$-248.18K	USD	Annual
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-1.65M	USD	Annual
Depreciation	`Depreciation`	$83.70K	USD	Annual
Provision for bad debts	`AllowanceForLoanAndLeaseLossRecoveryOfBadDebts`	$-1.15K	USD	Annual
Stock compensation	`ShareBasedCompensation`	$679.86K	USD	Annual
Stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$380.85K	USD	Annual
Amortization of beneficial conversion feature	`OtherAmortizationOfDeferredCharges`	$21.65K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$30.82K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$38.26K	USD	Annual
Due to related parties	`IncreaseDecreaseInDueToRelatedParties`	-	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayable`	$368.36K	USD	Annual
Taxes payable	`IncreaseDecreaseInAccruedTaxesPayable`	$434.38K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$36.36K	USD	Annual
Net cash provided by (used in) operating activities- continuing operations	`NetCashProvidedByUsedInContinuingOperations`	$40.15K	USD	Annual
Net cash provided by (used in) operating activities- discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$531.79K	USD	Annual
Net cash provided operating activities	`NetCashProvidedByUsedInOperatingActivities`	$571.94K	USD	Annual
Cash paid for purchase of fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$-57.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-57.00K	USD	Annual
Repayment of notes payable	`RepaymentsOfNotesPayable`	$-328.00	USD	Annual
Replayment for loans payable	`RepaymentsOfLongtermLoansFromVendors`	$-9.99K	USD	Annual
Changes in restricted cash	`IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities`	$7.82K	USD	Annual
Proceeds from bank overdraft	`ProceedsFromRepaymentsOfBankOverdrafts`	-	USD	Annual
Proceeds from issuance of short term notes	`ProceedsFromIssuanceOfDebt`	$150.00K	USD	Annual
Repayment of related party notes	`RepaymentOfNotesReceivableFromRelatedParties`	$-203.54K	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$382.50K	USD	Annual
Net cash provided by financing activities- continuing operations	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$326.50K	USD	Annual
Net cash provided by financing activities- discontinued operations	`NetCashProvidedByUsedInFinancingActivitiesDisContinuingOperations`	$-698.53K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-372.07K	USD	Annual
Effect of exchange rate on cash	`EffectOfExchangeRateOnCash`	$71.36K	USD	Annual
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$214.22K	USD	Annual
Cash, beginning of year	`Cash`	$88.15K	USD	Point-in-time
Cash, beginning of year	`Cash`	$-126.07K	USD	Point-in-time
Cash, end of year	`Cash`	$88.15K	USD	Point-in-time
Cash, end of year	`Cash`	$-126.07K	USD	Point-in-time
Cash paid for interest	`InterestPaid`	$80.53K	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Common stock issued as a result of conversion of convertible notes payable	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	197,730.00	shares	Annual
Common Stock issued as a result of conversion of short term notes payable	`StockIssuedDuringPeriodValueOther`	$28.79K	USD	Annual
Common Stock issued as a result of conversion of short term notes payable	`StockIssuedDuringPeriodValueOther`	$127.08K	USD	Annual
Common stock surrendered as part of disposition of subsidiary	`SurrenderOfSharesAsPartOfSaleOfSubsidiaryValue`	$-277.50K	USD	Annual

Stockholders Equity 24 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Value	`StockholdersEquity`	$-3.07M	USD	Point-in-time
Beginning Balance, Value	`StockholdersEquity`	$-3.21M	USD	Point-in-time
Beginning Balance, Value	`StockholdersEquity`	$-2.73M	USD	Point-in-time
Surrender of shares as part of sale of subsidiary, Value	`SurrenderOfSharesAsPartOfSaleOfSubsidiaryValue`	$-277.50K	USD	Annual
Disposition of subsidiary	`GainOrLossOnSaleOfStockInSubsidiary`	$1.01M	USD	Annual
Common stock issued for convertible note, Shares	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	197,730.00	shares	Annual
Common stock issued for convertible note, Value	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$1.48M	USD	Annual
Common stock issued for convertible note, Value	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$197.73K	USD	Annual
Common stock issued for short term note, Value	`StockIssuedDuringPeriodValueOther`	$28.79K	USD	Annual
Common stock issued for short term note, Value	`StockIssuedDuringPeriodValueOther`	$127.08K	USD	Annual
Shares issued for cash, Value	`StockIssuedDuringPeriodValueNewIssues`	$127.50K	USD	Annual
Shares issued for cash, Value	`StockIssuedDuringPeriodValueNewIssues`	$382.50K	USD	Annual
Issuance of shares for services, Value	`StockIssuedDuringPeriodValueIssuedForServices`	$380.85K	USD	Annual
Stock option compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$1.25M	USD	Annual
Stock option compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$679.86K	USD	Annual
Beneficial conversion feature of debt issuances	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$45.00K	USD	Annual
Beneficial conversion feature of debt issuances	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$90.45K	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent`	$71.36K	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent`	$311.86K	USD	Annual
Net loss	`NetIncomeLoss`	$-1.90M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.53M	USD	Annual
Ending Balance, Value	`StockholdersEquity`	$-3.07M	USD	Point-in-time
Ending Balance, Value	`StockholdersEquity`	$-3.21M	USD	Point-in-time
Ending Balance, Value	`StockholdersEquity`	$-2.73M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.